Affiliation:
1. Department of Pharmaceutics, University of Washington, Seattle 98195, USA.
Abstract
Stavudine (5 mg/kg of body weight; n = 7) or didanosine (3.2 mg/kg; n = 4) was administered as an intravenous bolus to pregnant pigtailed macaques (Macaca nemestrina) near term and 4 to 5 weeks postpartum. No significant differences were found between the prenatal and postpartum total plasma drug clearance, steady-state volume of distribution, terminal plasma drug half-life, mean body residence time, or recovery of unchanged drug in urine. These data indicate that pregnancy does not affect the pharmacokinetics of stavudine or didanosine in M. nemestrina.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference23 articles.
1. 2~,3~-Didehydro-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial;Browne M. J.;J. Infect. Dis.,1993
2. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment;Connor E. M.;N. Engl. J. Med.,1994
3. In vitro and in vivo disposition and metabolism of 3~-deoxy-2~,3~-didehydrothymidine;Cretton E. M.;Antimicrob. Agents Chemother.,1993
4. In vitro toxicity of 3~-azido-3~-deoxythymidine, carbovir and 2~,3~-didehydro-2~,3~- dideoxythymidine to human and murine hematopoietic progenitor cells;Du D.;Br. J. Haematol.,1992
5. Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex;Dudley M. N.;J. Infect. Dis.,1992
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献